iNDX.Ai Announces iCore Compliance with HIPAA
Sep 16, 2019
Compliance with HIPAA.
Cupertino, CA – May 19, 2019, iNDX Technology, Inc. d/b/a iNDX.Ai, the leader for managing Immuno-Oncology clinical trials and translational research. iNDX.Ai helps scientists, researchers, and principal investigators find a cure for cancer by combining innovations in science with innovations in technology. We provide a SaaS-based model that provides deeper insights, accelerates scientific discovery, and enable better outcomes , has announced compliance with the Health Insurance Portability and Accountability Act of 1996.
The Privacy Rule or Standards for the Privacy of Individually Identifiable Health Information, issued by the Department of Health and Human Services implements the requirement of the Health Insurance Portability and Accountability Act of 1996. It establishes a set of national standards for the protection of certain health information. The standards address the use and disclosure of individuals’ health information — called protected health information (PHI) — by organizations subject to the Privacy Rule — called covered entities — for various purposes including research. It also sets standards for individuals’ privacy rights to gain access to, be informed of, and control how their health information is used.
Protected health information (PHI) is individually identifiable health information that is held or transmitted by a covered entity (or its business associate) in any form or media, whether electronic, paper or oral. Individually identifiable health information includes common identifiers such as name, address, social security number, date of birth, or any other information that can be used to identify the individual.
iNDX.Ai is pleased to announce this further compliance capability in a software platform already recognized for compliance strength and Data management. iCore, designed for the large enterprise, continues to offer competitive advantage via scalability of its unified architecture and continual addition of stringent compliance benchmarks across multiple industries.
About iNDX Technology, Inc.
iNDX.Ai is a Silicon Valley-based Bio-IT company that has developed iCore, an innovative informatics platform that delivers novel insights and accelerates the drug development process for precision medicine. We are a highly motivated team of entrepreneurs, doctors, engineers, and data scientists with a mission to develop innovative software products that can help our collaborators find a cure for cancer and make a global societal impact. The genomics revolution has created a data tsunami. We have developed a novel approach for managing Immuno-Oncology clinical trials and translational research.
We provide the most advanced, accessible, and comprehensive suite of software solutions in the field of translational research. Our offerings enable users to aggregate, analyze, visualize, interrogate biomedical data and gather strategic and predictive insights in a secure cloud-based environment. For more information, please visit http://www.indx.ai/.
Contact Us ADDRESS: 21580 Stevens Creek Blvd, #204, Cupertino, CA 95014, US PHONE NUMBER: +1 408-548-0405 EMAIL:email@example.com